Bionano Genomics (BNGO) Amortization of Deferred Charges (2019 - 2021)
Bionano Genomics recorded quarterly Amortization of Deferred Charges of -$205000.0 in Q3 2021, down 401.47% quarter-over-quarter from $68000.0 in Q2 2021, and down 168.11% year-over-year from $301000.0 in Q3 2020.
Bionano Genomics' Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at -$205000.0 for Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Bionano Genomics | 14.92 Mn | 539,417.67 | 3.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -205,000.00 |
| Sep 30, 2021 | -205,000.00 |
| Jun 30, 2021 | 68,000.00 |
| Jun 30, 2021 | 68,000.00 |
| Mar 31, 2021 | 315,000.00 |
| Mar 31, 2021 | 315,000.00 |
| Sep 30, 2020 | 301,000.00 |
| Sep 30, 2020 | 301,000.00 |
| Jun 30, 2020 | 272,000.00 |
| Jun 30, 2020 | 272,000.00 |
| Mar 31, 2020 | 379,000.00 |
| Mar 31, 2020 | 379,000.00 |
| Sep 30, 2019 | 227,000.00 |
| Sep 30, 2019 | 227,000.00 |
| Jun 30, 2019 | 247,000.00 |
| Jun 30, 2019 | 247,000.00 |
| Mar 31, 2019 | 49,000.00 |
| Mar 31, 2019 | 49,000.00 |